We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

47 hedge funds and large institutions have $25.5M invested in HOOKIPA Pharma in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

133% more call options, than puts

Call options by funds: $107K | Put options by funds: $46K

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

15% more funds holding

Funds holding: 41 → 47 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.05% less ownership

Funds ownership: 4.45% → 4.4% (-0.05%)

13% less capital invested

Capital invested by funds: $29.4M → $25.5M (-$3.85M)

Holders
47
Holders Change
+6
Holders Change %
+14.63%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
10
Reduced
7
Closed
3
Calls
$107K
Puts
$46K
Net Calls
+$61K
Net Calls Change
+$27K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$290K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$128K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$56.2K
4
Two Sigma Investments
Two Sigma Investments
New York
+$56K
5
Prudential Financial
Prudential Financial
New Jersey
+$46K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$803K
2
BC
BIT Capital
Germany
-$185K
3
TSS
Two Sigma Securities
New York
-$66.5K
4
XT
XTX Topco
Cayman Islands
-$31.8K
5
Millennium Management
Millennium Management
New York
-$11.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$29.3K -$11.7K -1,647 -29%
Charles Schwab
27
Charles Schwab
California
$25.8K – – –
Two Sigma Advisers
28
Two Sigma Advisers
New York
$25.3K +$25.3K +3,560 New
HF
29
HRT Financial
New York
$24K +$24.8K +3,487 New
DIM
30
DLK Investment Management
California
$22.8K – – –
Jane Street
31
Jane Street
New York
$18.5K +$18.5K +2,600 New
BPA
32
Beacon Pointe Advisors
California
$16.7K – – –
AC
33
Apella Capital
Connecticut
$16.6K – – –
Group One Trading
34
Group One Trading
Illinois
$12.4K – – –
IAIM
35
International Assets Investment Management
Florida
$10.1K – – –
UBS Group
36
UBS Group
Switzerland
$8.84K +$4.68K +657 +113%
TRCT
37
Tower Research Capital (TRC)
New York
$7.44K +$584 +82 +9%
Bank of America
38
Bank of America
North Carolina
$4.56K -$28 -4 -0.6%
NS
39
NBC Securities
Alabama
$4K -$2.49K -350 -37%
Osaic Holdings
40
Osaic Holdings
Arizona
$2.85K – – –
Wells Fargo
41
Wells Fargo
California
$390 +$7 +1 +2%
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$240 – – –
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$235 – – –
Northwestern Mutual Wealth Management
44
Northwestern Mutual Wealth Management
Wisconsin
$71 +$71 +10 New
Citigroup
45
Citigroup
New York
$53 – – –
TC
46
Truvestments Capital
Florida
$18 +$21 +3 New
JP Morgan Chase
47
JP Morgan Chase
New York
$10 – – –
BC
48
BIT Capital
Germany
– -$185K -22,889 Closed
TSS
49
Two Sigma Securities
New York
– -$66.5K -8,214 Closed
ASN
50
Advisory Services Network
Georgia
– -$6 -1 Closed
1
2

HOOK Hedge Fund Activity: Q1 2024 in Review

47 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q1 2024, worth a combined $25.5M — down 13% from $29.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new HOOK positions and 3 closed out — a net gain of 6 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $290K. The largest seller was Morgan Stanley, cutting an estimated $803K.

  • 47 institutional investors held HOOKIPA Pharma (HOOK) as of Q1 2024, up from 41 in Q4 2023.
  • Funds reported $25.5M of HOOKIPA Pharma stock for Q1 2024, down 13% quarter-over-quarter.
  • 9 funds opened new HOOKIPA Pharma positions in Q1 2024 and 3 closed out, a net change of +6 holders.
  • The largest HOOKIPA Pharma buyer in Q1 2024 was Acadian Asset Management, an estimated $290K added.
  • The largest HOOKIPA Pharma seller in Q1 2024 was Morgan Stanley, an estimated $803K sold.

Based on aggregated 13F filings for Q1 2024.